Thursday, December 15, 2011
Monday, December 12, 2011
Wells Fargo Retail Banking Jobs
Wells Fargo has a need for tellers.There are openings for this basic retail banking position at multiple locations.For example,tellers are now being hired in Greater Central Maryland and Western Baltimore;Charles County;and Greater Prince Georges County,Maryland.Many banking careers have begun at the teller level.
The San Francisco-based company provides a full range of financial services,from banking and insurance to investments and commercial finance.It has 1.3 trillion dollars in assets and more than 270,000 team members across more than 80 lines of business.Noted investor Warren Buffett owns a substantial part of the company.
For more information or to apply,visit www.wellsfargo.com and select Careers.
Wells Fargo&Co.(WFC)
The San Francisco-based company provides a full range of financial services,from banking and insurance to investments and commercial finance.It has 1.3 trillion dollars in assets and more than 270,000 team members across more than 80 lines of business.Noted investor Warren Buffett owns a substantial part of the company.
For more information or to apply,visit www.wellsfargo.com and select Careers.
Wells Fargo&Co.(WFC)
Sunday, December 11, 2011
Chinese Trade Suffers From Euro Crisis-and how this could affect you
Chinese exports are slowing down and its trade surplus is shrinking,newly released figures show.China's export growth fell to 13.8% in November-the least growth since December 2009.Its trade surplus dropped to 14.5 billion dollars,down from 17 billion in October and below the estimate. This is a result of slowing demand from China's European trading partners because of the current debt crisis,as well as a hesitant U.S. consumer from the weak employment picture.
China is observing its 10th anniversary of joining the World Trade Organisation.President Hu Jintao said China will not deliberately pursue a trade surplus.China has fulfilled its promises to the World Trade Organisation.We will work hard for a balance of payments.China has some unbalanced and unsustainable elements that have to be improved,Mr.Hu admitted,responding to European and U.S. criticism.
As for the slowdown in export growth,Chinese officials said China may continue cutting bank reserve requirements in order to stimulate growth by encouraging lending.China must keep growing at a robust pace to provide jobs for its rapidly urbanising population.
A slowdown in China could have negative implications for the many large U.S. multinational corporations,such as Ford Motor,General Motors,General Electric and Wal-Mart,who rely on China for a portion of their own growth now.A deterioration in business conditions in China may hinder the U.S. economy in consequence of globalism.
iShares Trust FTSE/Xinhua China 25 index(FXI)
China is observing its 10th anniversary of joining the World Trade Organisation.President Hu Jintao said China will not deliberately pursue a trade surplus.China has fulfilled its promises to the World Trade Organisation.We will work hard for a balance of payments.China has some unbalanced and unsustainable elements that have to be improved,Mr.Hu admitted,responding to European and U.S. criticism.
As for the slowdown in export growth,Chinese officials said China may continue cutting bank reserve requirements in order to stimulate growth by encouraging lending.China must keep growing at a robust pace to provide jobs for its rapidly urbanising population.
A slowdown in China could have negative implications for the many large U.S. multinational corporations,such as Ford Motor,General Motors,General Electric and Wal-Mart,who rely on China for a portion of their own growth now.A deterioration in business conditions in China may hinder the U.S. economy in consequence of globalism.
iShares Trust FTSE/Xinhua China 25 index(FXI)
Friday, December 9, 2011
A Successful Partnership:GlaxoSmithKline and Human Genome Sciences
British pharma titan GlaxoSmithKline is building on research carried out by Rockville,Maryland biotech firm Human Genome Sciences.Two of GSK's pipeline projects are based on HGS technology.
Darapladib is an inhibitor of the Lp-PLA2 enzyme,which is believed to be a risk factor for coronary heart disease and ischemic stroke.It is a potentially important new treatment for prevention of cardiovascular events.The candidate drug discovered by GSK using an HGS technology is in a Phase 3 trial for efficacy and safety of treatment.
Albiglutide is a biological product created by HGS and licensed by GSK IN 2004.It is designed to act throughout the body to help maintain blood glucose levels and control appetite.This potential long term treatment for type 2 diabetes is also in a Phase 3 trial.
HGS has a substantial financial interest in both of these GSK products which its research has had a formative influence on.
GlaxoSmithKline and Human Genome Sciences are also co-owners and developers of Benlysta,the first new lupus treatment approved in the U.S. in 50 years.
GlaxoSmithKline(GSK),Human Genome Sciences(HGSI)
Darapladib is an inhibitor of the Lp-PLA2 enzyme,which is believed to be a risk factor for coronary heart disease and ischemic stroke.It is a potentially important new treatment for prevention of cardiovascular events.The candidate drug discovered by GSK using an HGS technology is in a Phase 3 trial for efficacy and safety of treatment.
Albiglutide is a biological product created by HGS and licensed by GSK IN 2004.It is designed to act throughout the body to help maintain blood glucose levels and control appetite.This potential long term treatment for type 2 diabetes is also in a Phase 3 trial.
HGS has a substantial financial interest in both of these GSK products which its research has had a formative influence on.
GlaxoSmithKline and Human Genome Sciences are also co-owners and developers of Benlysta,the first new lupus treatment approved in the U.S. in 50 years.
GlaxoSmithKline(GSK),Human Genome Sciences(HGSI)
Monday, December 5, 2011
Experts: Inside the Tough Job Search-plus who is hiring now
The Labor Department posted a November jobs gain of 120,000-below the 125,000 estimate.At this point in our recovery,it's a disappointing number,said John Allison,Professor at Wake Forest School of Business and former CEO of BB&T.It's not a bad number,but at this point in the cycle we ought to be creating more jobs.
Businesses are concerned about Europe,rising taxes and regulations.Businesses create jobs through innovation,which is hindered by regulation,Mr.Allison pointed out.
It's very expensive to hire and fire,adds Jeanne Branthover of Boyden Global Executive Search.It's also very expensive to hire and wait for new workers to add value.That's why it's those who are already working who are being hired.
If things are better,they are ready to expand hiring.Plans are already in place so they are ready to immediately pull the trigger if things keep looking up,Ms.Branthover revealed.
Among large companies who are hiring now in spite of these factors are Wells Fargo(10,000+ jobs);Sears Holdings(1,000+);and Morgan Stanley Smith Barney(1,000+).
Branch Banking and Trust(BBT)
Businesses are concerned about Europe,rising taxes and regulations.Businesses create jobs through innovation,which is hindered by regulation,Mr.Allison pointed out.
It's very expensive to hire and fire,adds Jeanne Branthover of Boyden Global Executive Search.It's also very expensive to hire and wait for new workers to add value.That's why it's those who are already working who are being hired.
If things are better,they are ready to expand hiring.Plans are already in place so they are ready to immediately pull the trigger if things keep looking up,Ms.Branthover revealed.
Among large companies who are hiring now in spite of these factors are Wells Fargo(10,000+ jobs);Sears Holdings(1,000+);and Morgan Stanley Smith Barney(1,000+).
Branch Banking and Trust(BBT)
Sunday, December 4, 2011
BHP Shares Rise On Gillard Policy Win
Shares of natural resource firm BHP Billiton rose Monday morning on news that the Australian Labour Party is lifting its ban on the export of uranium to India.Prime Minister Julia Gillard said the move will help the Australian economy by tapping into India's demand for energy.Her critics pointed out that India hasn't yet signed the nuclear non-proliferation treaty.
Japanese shares also rose on optimism that the Euro debt crisis is being seriously addressed.Jesper Koll,Head of Japanese Equity Research at JP Morgan Japan,described Japan as the forgotten angel.It is showing good job creation,wage growth and policy decisions.Goldman Sachs agreed,saying Japanese profits could rise significantly in 2012.
Mr.Koll is a longtime resident of Japan and has many years of experience analysing its economy.
BHP Billiton Ltd.(BHP),iShares MSCI Japan Index Fund(EWJ),JP Morgan Chase(JPM),Goldman Sachs(GS)
Japanese shares also rose on optimism that the Euro debt crisis is being seriously addressed.Jesper Koll,Head of Japanese Equity Research at JP Morgan Japan,described Japan as the forgotten angel.It is showing good job creation,wage growth and policy decisions.Goldman Sachs agreed,saying Japanese profits could rise significantly in 2012.
Mr.Koll is a longtime resident of Japan and has many years of experience analysing its economy.
BHP Billiton Ltd.(BHP),iShares MSCI Japan Index Fund(EWJ),JP Morgan Chase(JPM),Goldman Sachs(GS)
Friday, December 2, 2011
Novartis Honored By Fortune Magazine
Swiss health care firm Novartis was honored by Fortune magazine as its Most Admired pharmaceutical company for 2011.It recieved an overall score of 7.02,folowed by Merck at 6.80 and Johnson&Johnson at 6.72.Last year,Novartis came in third.
The rank was decided by a survey of pharmaceutical executives,directors and analysts.They used nine criteria such as investment value and social responsibility.
Novartis is the world's third-largest pharmaceutical firm by sales.
One of its leading products is Gleevec(imatinib),a pill for patients with certain forms of chronic myeloid leukemia(CML) and gastrointestinal stromal tumors(GIST).Gleevec is also approved in the U.S.,EU and Japan for a form of acute lymphoblastic leukemia(ALL) and other blood disorders.It has helped many patients stay in remission for several years.
Novartis also owns the OTC brands Theraflu and Comtrex.The company has an assistance program for uninsured or underinsured patients.
Novartis AG(NVS)
The rank was decided by a survey of pharmaceutical executives,directors and analysts.They used nine criteria such as investment value and social responsibility.
Novartis is the world's third-largest pharmaceutical firm by sales.
One of its leading products is Gleevec(imatinib),a pill for patients with certain forms of chronic myeloid leukemia(CML) and gastrointestinal stromal tumors(GIST).Gleevec is also approved in the U.S.,EU and Japan for a form of acute lymphoblastic leukemia(ALL) and other blood disorders.It has helped many patients stay in remission for several years.
Novartis also owns the OTC brands Theraflu and Comtrex.The company has an assistance program for uninsured or underinsured patients.
Novartis AG(NVS)
Subscribe to:
Posts (Atom)